Genital Candidiasis (Genital Thrush)

Comments from Expert Advisory Group

  1. Candida can lead to genital symptoms in men and women. Asymptomatic colonisation is common and does not usually require treatment. The majority of cases are caused by Candida albicans.
  2. In women, genital candidiasis can lead to vulvitis, vaginitis and / or vulvovaginitis. Symptoms may include thick white vaginal discharge, vulvovaginal discomfort, burning or itch. Other symptoms include dyspareunia / dysuria and signs include vulval erythema / fissuring and satellite lesions.The diagnosis can be made clinically on the basis of the description and appearance of the vulva and/or vaginal discharge. A high vaginal swab (HVS) is not required to start empiric treatment on first presentation.  A HVS can be useful in women experiencing recurrent symptoms or failing to respond to treatment in order to confirm the presence of candida, the type of candida species and sensitivities where resistance to azoles is suspected.
  3. All women should be examined and alternative diagnoses including genital dermatoses should be considered. Consider atrophic vaginitis, which is a common symptom of the perimenopause and menopause and can also occur several years after the menopause.
  4. In women, consider sexually transmitted causes of vaginal discharge on the basis of sexual history and consider testing for chlamydia, gonorrhoea and trichomoniasis.
  5. The definition of recurrent vulvovaginal candidiasis is accepted as four or more episodes per year, two of which are confirmed on microscopy or culture when symptomatic. Careful consideration should be given to alternative diagnoses such as lichen sclerosis, eczema or other dermatological conditions. Referral to Genitourinary Medicine or Dermatology may be warranted. The  vulval skin care leaflet from the British Association of Dermatology contains general advice for patients.
  6. In men, genital candidiasis can present with a balanitis with an associated itch. Men should be examined and the diagnosis can be made by the appearance of the glans penis. Examination is particularly important if symptoms don’t resolve and alternative diagnoses should be considered.
  7. Identify and optimise the management of underlying conditions or risk factors for genital thrush such as undiagnosed or poorly controlled diabetes. Consider underlying immunosuppression in those presenting with severe, recurrent cases.
  8. In general, treatment of asymptomatic sexual partners is not recommended.
  9. Repeated single doses of fluconazole increase the likelihood of azole resistance and should be avoided where possible. Provision of a prescription for single dose fluconazole with a course of antibiotics “just in case” is generally not recommended.

Treatment Options

  • Good genital skin care is central to the management and prevention of genital candidiasis, particularly vulvovaginal candidiasis. This includes avoidance of soap and shower gel and other potential irritants. Emollient creams may be used as a soap substitute, moisturiser and/or barrier cream (external use only). The  vulval skin care leaflet from the British Association of Dermatology contains general advice for patients.
  • Intravaginal and oral treatments have similar efficacy in the management of vulvovaginal candidiasis.  
  • 1% hydrocortisone with antifungal cream may ease symptoms of vulvitis and balanitis.
  • Atopic individuals may experience irritation with antifungal creams. Symptoms may settle with intravaginal antifungal treatment alone.

There are many treatment options available, the table below is not exhaustive.

GENITAL CANDIDIASIS (GENITAL THRUSH) ANTIMICROBIAL TREATMENT TABLE

Vulvovaginal candidiasis 

  • Short course intravaginal formulations effectively treat uncomplicated vulvovaginal candidiasis. 
  • Choice of treatment should be made on the basis of location of symptoms and patient choice. A number of preparations are available over-the-counter (OTC). There may be intermittent supply issues with some products. Consider contacting supplying pharmacy regarding current availability.  
  • If there are vulval symptoms, consider clotrimazole cream for external relief of symptoms in addition to intravaginal or systemic antifungal if required. 
Drug Dose Duration Notes

Clotrimazole 
(Canesten®) pessary 

Available OTC 

500 mg intravaginal pessary

 

Single dose

 

Insert pessary using applicator high into the vagina at night. 

 

These products may damage latex contraceptives, alternative precautions advised during use and for at least 5 days after using product. 

 

 

 

 

 

 

 

 

OR

Clotrimazole pessary + Clotrimazole 2% cream  

(Canesten Combi® pessary + cream) 

Available OTC 

500mg intravaginal pessary  

 

 

Apply cream to the affected area every 8 to 12 hours 

Pessary: Single dose 

 

 

Cream: Until symptoms resolved, up to 7 days.  

OR

Econazole (Gyno-Pevaryl®) pessary 

Available OTC 

150 mg intravaginal pessary

 

Single dose

 

OR

Fluconazole oral*  

Prescription only 

 

 

 

 

150 mg

 

 

 

 

 

Single dose

 

 

 

 

 

Note: Repeated single doses of fluconazole can increase the likelihood of azole resistance.

Avoid fluconazole (and all oral azoles) in pregnancy. 

See HPRA caution in women of childbearing potential* 

Check for drug interactions 

Topical creams listed below are rarely sufficient to treat vulvovaginal thrush but can be employed as an adjunct to intravaginal or systemic preparations to alleviate external vulval symptoms. 
Clotrimazole 1% or 2% cream

Available OTC

Apply to the affected area every 8 to 12 hours 

Until symptoms resolved, up to 7 days. 

These products may damage latex contraceptives, alternative precautions advised during use and for at least 5 days after using product.

 

 

 

 

 

OR

Clotrimazole 1% + Hydrocortisone 1% cream

(Canestan HC® cream) 

Prescription only

Apply a thin layer to the affected area every 12 hours 

 

Until symptoms resolved, up to 7 days. 

 

Vulvovaginal candidiasis in pregnancy  

Clotrimazole (Canesten®) pessary

500 mg  intravaginal pessary at night

up to 7 days

During pregnancy the pessary should be inserted without using an applicator. Advise to insert the narrow end of the pessary first as high into the vagina as comfortable. Wash hands before and after use.

 

 

OR
Econazole (Gyno-Pevaryl®) pessary 150 mg intravaginal pessary at night  7 days

Clotrimazole 1% or 2% cream

 

Apply to the affected area every 8 to 12 hours 

 

up to 7 days

 

 

Topical creams are rarely sufficient to treat vulvovaginal thrush but can be employed as an adjunct to intravaginal preparations to alleviate external vulval symptoms. 

Recurrent vulvovaginal candidiasis (VVC)

See definition of recurrent VVC in expert advisory comment 5 above. 

Fluconazole oral*

Prescription only

 

 

 

 

 150 mg

 

 

 

 

 

On days 1, 4 and 7, then weekly for 6 months

 

 

 

Check for drug interactions 

Avoid fluconazole (and all oral azoles) in pregnancy 

See HPRA caution in women of childbearing potential* 

Use with caution in patients with hepatic dysfunction.

Recurrent vulvovaginal candidiasis in pregnancy 

Clotrimazole (Canesten®) pessary

 

 

 

 

 

500 mg intravaginal pessary at night for up to max. 10-14 days according to symptomatic response

Followed by maintenance: 500 mg intravaginal pessary once weekly 

Duration detailed with dose

 

 

 

 

During pregnancy the pessary should be inserted without using an applicator. Advise to insert the narrow end of the pessary first as high into the vagina as comfortable. Wash hands before and after use.

 

 

 

Candida balanitis (Oral treatment rarely indicated) 

Clotrimazole 1% cream 

Available OTC

 

Apply to the affected area every 12 hours

 

Up to 14 days according to symptomatic response.

These products may damage latex contraceptives, alternative precautions advised during use and for at least 5 days after using product.

 

 

 

 

 

 

OR

Clotrimazole 1% + Hydrocortisone 1% cream 

(Canestan HC® cream) 

Prescription only 

Apply a thin layer to the affected area every 12 hours

 

 

Up to 14 days according to symptomatic response.

 * Women of childbearing potential, for whom fluconazole is prescribed, should be informed of the potential risks to the foetus:

  • After single dose treatment, a washout period of one week is recommended before pregnancy.
  • For longer courses of treatment appropriate contraception should be considered throughout the treatment period and for one week after the final dose.

Patient Information

Strategies to prevent recurrence of genital thrush include:

Safe Prescribing

Visit the safe prescribing page

Reviewed April 2024, minor update March 2025, November 2025

ICGP Logo